Breaking Finance News

Merck (ETR:MRK) stock price target increased to 101.00EUR, issued a report today by Joh. Berenberg Gossler & Co. KG

Having a price of 97.63EUR, Merck (ETR:MRK) traded -0.59% lower on the day. With the last close up 5.98% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Merck has recorded a 50-day average of 62.57EUR and a two hundred day average of 58.63EUR. Volume of trade was up over the average, with 12,204,208 shares of MRK changing hands over the typical 10,050,800

In a report released on 10/14/2016 Joh. Berenberg Gossler & Co. KG increased the stock price target of Merck (ETR:MRK) to 101.00EUR stating a potential upside of 0.03%.

On 10/04/2016, BNP PARIBAS released a statement on Merck (ETR:MRK) upped the target price from 0.00EUR to 114.00EUR that suggested an upside of 0.19%.

Performance Chart

Merck (ETR:MRK)

With a market cap of 0 EUR, Merck has 52 week low of 47.97EUR and a 52 week high of 64.86EUR with a P/E ratio of 34.09 .

In addition to Joh. Berenberg Gossler & Co. KG reporting its stock price target, a total of 20 brokerages have released a research note on MRK. The one year target is 61.60EUR with 2 equity analysts rating the company a strong buy, seven brokers rating the stock a buy, thirteen analysts rating the company a hold, zero brokerages rating the company a underperform, and lastly zero equity analysts rating the company a sell.

More About Merck (ETR:MRK)

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *